Stemtech Corporation

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Stemtech Corp. engages in the development of nutritional supplements. It offers RCM System, stemrelease3, StemFlo, MigraStem, Collet One, OraStem, and OraStem 5-Pack. It operates through the following geographical segments: North America, Latin America, and Asia. The North America segment refers to its subsidiaries in United States and Canada. The Latin America segment includes subsidiaries in Mexico and Ecuador. The Asia segment relates to its subsidiaries in Malaysia and Taiwan. The company was founded on September 4, 2009 and is headquartered in Naples, FL.

NAPLES, FL / ACCESSWIRE / September 4, 2024 / ("STEK") Stemtech Corporation, the pioneer and trailblazer in the stem cell nutrition sector, is proud to announce that OTC Markets has approved us to quote as an OTCQB stock, symbolizing a commitment to transparency and investor confidence. As we consolidate our footprint in the United States, Mexico, Ecuador, Canada and Taiwan, this milestone is a testament to our dedication to global health through groundbreaking stem cell nutrition, skin care, oral care and as recently announced on August 22, pet care technologies.

Stemtech Corporation Announces Uplist to OTCQB, Maintains Focus on Expansion and Transparency

NAPLES, FL / ACCESSWIRE / August 22, 2024 / Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of stemceutical™ products for humans offered since 2005, is proud to announce an exciting new product line into the pet health care industry with the launch of "StemPets™." This revolutionary product is designed to provide substantial health benefits to dogs, cats, and other beloved pets, tapping into the $303 billion pet health care market.

Stemtech Expands Into The $303 Billion Pet Health Care Market With Launch Of Stempets(TM)

NAPLES, FL / ACCESSWIRE / July 18, 2024 / STEMTECH CORPORATION, (OTC Pink:STEK) As CEO of the Company, I want to publicly address the recent issues which delayed our annual "10K" and "10Q" filings with the SEC. These delays were due to several factors unrelated to any internal issues within Stemtech.

STEMTECH CORPORATION Update to Shareholders & Independent Business Partners

Industry Recognition: Stemtech Ranked Top 5% in Direct Selling by 'Business for Home'" NAPLES, FL / ACCESSWIRE / April 19, 2024 / (OTCQB:STEK) Stemtech Corporation, a leader in innovative health and wellness solutions through stem cells technology, is proud to announce that it is on track to achieve the CEO and Chairman's goal of becoming cash flow positive. With a focus on revenue growth in existing countries and expansion into new markets, Stemtech is experiencing success.

Stemtech Corporation on Track for CEO and Chairman's Goal for Growth and Global Expansion

NAPLES, FL / ACCESSWIRE / April 2, 2024 / Stemtech Corporation (OTCQB:STEK), a leading company in the stem cell nutritional sector, is thrilled to announce Mr. Darryl Green will direct our Rebranding Project, marking a significant milestone in the company's journey towards enhancing its digital footprint and strengthening its market presence.

Stemtech Corporation Announces Darryl V. Green to Direct Company Rebranding Project

Revolutionizing Health and Wellness Through Natural Stem Cell Release NAPLES, FL / ACCESSWIRE / March 7, 2024 / Stemtech (OTCQB:STEK), a leading provider of innovative stem cell-based nutraceuticals, announces its staggering growth in the market, with demand surging. Stemtech's proprietary products, including its trademark Stemceuticals™, are revolutionizing the health and wellness industry by harnessing the power of the body's own stem cells.

Stemtech Surges Ahead: Meeting Global Demand with Innovative Stem Cell Nutraceuticals

Unlocking Prosperity: Business Opportunities Await! All Entrepreneurs Invited to Seize the Moment NAPLES, FL / ACCESSWIRE / February 21, 2024 / (OTCQB:STEK) Stemtech Corporation, the pioneering leader in stem cell nutrition for nearly 20 years, is thrilled to invite individuals to two exclusive events, designed to explore the remarkable benefits of stem cell nutrition and the unparalleled business opportunities it presents.

Exclusive Events in Doral Florida and Guadalajara Mexico to Showcase Stemtech Revolutionary Stem Cell Nutritional Products

Stemtech Corporation Secures Exclusive Agreement to Propel Stemtech's Revolutionary Stem Cell Nutrition Across Six African Nations NAPLES, FL / ACCESSWIRE / January 31, 2024 / Stemtech Corporation (OTCQB:STEK), a leading innovator in patented stem cell nutrition health products, announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya. The Agreement, effective January 29th, 2024, grants the license to purchase, use, market, and distribute Stemtech's cutting-edge health related products within the designated Territory(s), including Kenya, Uganda, Tanzania, Ghana, Democratic Republic of Congo and Nigeria.

Stemtech Corporation Expands Global Reach with New License Agreement in Africa

Before the REORGANIZATION, Stemtech thrived IN COLOMBIA, generating $10 million and boasting 3,000 IBPs in the Colombian market. NAPLES, FL / ACCESSWIRE / December 12, 2023 / STEMTECH CORPORATION (OTCQB:STEK) Stemtech, the pioneer in all-natural, plant-based stem cell nutrition wellness solutions, announces a significant step in its global expansion strategy with the re-entry into the Colombian market and the planned expansion of its product line in Ecuador.

"Stemtech's Annual Incentive Cruise Sets Sail With Top Earners on Board; Colombia Pre-Registration Now Open and Product Expansion Unveiled for Ecuador"

Company Achieves NEW Rank Advancements, Acknowledges Sales Directors, and Sets Course for Future Expansion NAPLES, FL / ACCESSWIRE / December 4, 2023 / Stemtech (OTCQB:STEK), the pioneer in all-natural, plant-based stem cell nutrition wellness solutions, proudly announces a significant milestone with the attainment of NEW Rank Advancements in the recent months in 2023. In these highest rank advancements, we see Diamond, Crown Diamond and Presidents Club achievements.

Stemtech Continues to Demonstrate Remarkable Growth and Innovation in 2023

Delving into Stem Cell Science, Nutrition vs. Therapy, Colombia Pre-Launch, Ecuador Expansion, , Business and Investor Opportunities, and High Demand for Our Product NAPLES, FL / ACCESSWIRE / October 16, 2023 / Stemtech Corporation is thrilled to announce that its CEO, Charles S.

Stemtech Corporation Chairman & CEO Charles S. Arnold and President & COO John W.

Approach and Global Impact Solidify Stemtech's Position as Leader in Stem Cell Nutrition NAPLES, FL / ACCESSWIRE / September 5, 2023 / Stemtech Corporation (OTCQB:STEK) Stemtech Corporation, The Pioneer in stem cell nutrition, 'stemceuticals™,' and cutting-edge skincare, is excited to announce a continuing trend in the growth of its Independent Business Partners (IBPs). With consistent month-over-month new IBPs and customer increases (May - August at 14.4%, 9.8%, 14.7% and 14.8% respectively) in addition to the press release of August 7th where Stemtech reported 20% revenue growth in our two top markets of the U.S. and Mexico.

Pioneering Stem Cell Nutrition Company Elevating Wellness and Prosperity Together

Stemtech Unveils Bold Vision ‘Grand China Market Plan' to Supercharge China's Thriving Health and Wellness Landscape Amidst $ 683 Billion Wellness Industry Surge MIRAMAR, FL / ACCESSWIRE / August 14, 2023 / (OTCQB:STEK) As China's health and wellness industry, valued at an impressive USD $683 billion, undergoes a profound transformation due to the pandemic, Stemtech Corporation, the pioneer in stem cell nutrition, unveils its strategic "Grand China Market Plan." John W. Meyer, President and COO of Stemtech Corporation, announces "I am excited about the ‘Grand China Market Plan', expanding through our Stemtech Taiwan Holding, Taiwan Branch operations.

Stemtech Announces China Market Expansion

Achieves 20% Revenue Surge in Key Markets, Demonstrating Success of Strategic Initiatives and Growing Market Demand MIRAMAR, FL / ACCESSWIRE / August 7, 2023 / Stemtech Corporation (OTCQB:STEK) John W. Meyer, President and COO of Stemtech Corporation, says "Stemtech, the pioneer of stem cell nutrition, is thrilled to provide an enthusiastic update to its esteemed shareholders, highlighting the remarkable business advancements achieved through its Business Academies and the dynamic efforts of its newly appointed Director of New Business Development, Jeff Weisberg.

Stemtech Showcases Remarkable Strides in Business Development and Revenue Growth

Growth Sparks Excitement as STEMTECH Achieves Record-Breaking Surge in New Independent Business Partners MIRAMAR, FL / ACCESSWIRE / July 17, 2023 / Innovation-driven company STEMTECH proudly announces a groundbreaking achievement that has set our Independent Business Partners (IBPs) abuzz. The month of June 2023 witnessed a surge in new IBPs, surpassing all previous distributor sign-up records in the past year.

STEMTECH (OTCQB: STEK) Shatters Records with Surge in New Recruits, Paving the Way for a Thrilling Era of Opportunity in the Booming Global Stem Cell Market

MIRAMAR, FL / ACCESSWIRE / July 6, 2023 / STEMTECH CORPORATION (OTCQB:STEK) is thrilled to announce significant progress in its debt reduction initiatives and current growth updates. Under the leadership of business veteran Charles S.

Stemtech Corporation Announces Additional Debt Conversions: Provides Growth Update

Charles S. Arnold, Stemtech CEO, leads the charge as company reduces debt and expands equity position, signaling commitment to global stem cell nutrition market. MIRAMAR, FL / ACESSWIRE / June 13, 2023 / STEMTECH CORPORATION, (OTCQB:STEK) Charles S.

Stemtech Corporation Empowers Growth With Debt-to-Equity Conversion, Strengthening Investor Confidence

MIRAMAR, FL / ACCESSWIRE / June 6, 2023 / John W. Meyer, President and COO of Stemtech (OTCQB:STEK), stated "in the 18 years that I have been involved with Stemtech, it is a distinct honor to have the Company voted 25th most trusted company in direct sales in a recent poll of thousands of global direct sales companies as reported by "Business For Home" publication (businessforhome.org) This poll was based upon the quality of products, business credibility, reputation, customer retention and acquisition, key leaders, track record, financial stability , reviews, recognition and more.

Stemtech Corporation Voted 25th Most Trusted Direct Sales Company in Business for Home Poll

MIRAMAR, FL / ACCESSWIRE / May 23, 2023 / Stemtech Corporation (OTCQB:STEK) Charles S. Arnold, Chairman and CEO of Stemtech, stated "When Stemtech completed its reverse merger, 3 convertible debt instruments were issued to separate institutional investors.

Stemtech Corporation Announces Debt Restructuring

Stemtech Corporation and Union Blue USA Announce Revolutionary Alliance which will partner Labor Union Members and Trade Associations with a direct selling company with broad-based health, wellness products and services, and personal business opportunity executed through mutually beneficial programs. MIRAMAR, FL / ACCESSWIRE / May 17, 2023 / STEMTECH CORPORATION (OTCQB:STEK) Charles S.

Stemtech Corporation and Union Blue Usa(TM) Announce Revolutionary Alliance To Improve Health and Wellness of Labor Union Members

Stemtech Corporation Engages Jeff M. Weisberg for Expansion of Stemtech Business for Sales Growth MIRAMAR, FL / ACCESSWIRE / May 8, 2023 / STEMTECH CORPORATION (OTCQB:"STEK") Stemtech President and COO, John W.

Stemtech Corporation Announces Jeff M. Weisberg as Director of New Business Development

Stemtech Corporation Announces Regional Business Academies in Mexico, US 2023 MIRAMAR, FL / ACCESSWIRE / April 28, 2023 / STEMTECH CORPORATION (OTCQB:STEK) announces Business Academies for their Independent Business Partners (IBPs) will be conducted in Aguas Calientes Mexico May 25 - 27 and in Las Vegas in the U.S. June 1 - 3. John W. Meyer, President and Chief Operating Officer, says "Stemtech is presenting training opportunities for our IBPs.

Stemtech Announces Business Academies For Mexico And U.S. Independent Business Partners

Stemtech Corporation Announces New Chief Administrative Officer Joins Executive Management Team MIRAMAR, FL / ACCESSWIRE / April 21, 2023 / STEMTECH CORPORATION - (OTCQB:STEK) announces Mr. I. Tufan Obuz as Chief Administrative Officer (CAO) Stemtech is pleased to announce the engagement of Mr.

Stemtech Announces New Chief Administrative Officer

Secures $7 Million Investment Enables Stemtech to Launch Colombia and Expanded Ecuador Product Lines MIRAMAR, FL / ACCESSWIRE / April 3, 2023 / Stemtech (OTCQB:STEK) has just executed a loan commitment for $7,000,000 with a family office specializing in healthcare. Stemtech CEO, Charles S.

Stemtech Corporation Announces $7 Million Investment

Stemtech Corporation Announces Regional Business Academies in Mexico, US and Taiwan for 2023 MIRAMAR, FL / ACCESSWIRE / March 3, 2023 / STEMTECH CORPORATION (OTCQB:STEK) announces Business Academies for their Independent Business Partners (IBPs) will be conducted in Mexico in May, the United States in June and Taiwan in October. John W. Meyer, President and Chief Operating Officer, says "I am excited that Stemtech is once again conducting important Business Academies, filled with training opportunities for our IBPs.

News for Stemtech Corporation Stock (STEK)